How Did ABP 710 Compare to Infliximab in Improving Symptoms of Rheumatoid Arthritis?
The following table shows the most common non-serious side effects considered by
the study doctor as related to treatment. These side effects occurred in at least 1%
of participants in any treatment group.
Most Common Non-serious Side Effects During the Study
Part 1 – First 22 Weeks Part 2 – After 22 Weeks
ABP 710 Infliximab then
ABP 710 Infliximab Infliximab only
only ABP 710
(278 (278 (121
(241 (119
participants) participants) participants)
participants) participants)
Common cold 8 (3%) 4 (1%) 6 (3%) 4 (3%) 3 (3%)
Low white blood cell 2 (1%) 0 4 (2%) 0 3 (3%)
count
Allergic reaction 1 (less than 1%) 2 (less than 1%) 2 (less than 1%) 3 (3%) 0
Infection of nose and 3 (1%) 2 (less than 1%) 0 3 (3%) 2 (2%)
upper throat
Rheumatoid arthritis 5 (2%) 3 (1%) 4 (2%) 1 (less than 1%) 1 (less than 1%)
Nausea 4 (1%) 3 (1%) 0 0 0
Painful irritation of the 4 (1%) 1 (less than 1%) 4 (2%) 1 (less than 1%) 1 (less than 1%)
tubes in the lungs
(bronchitis)
Allergic skin reaction 0 5 (2%) 1 (less than 1%) 1 (less than 1%) 2 (2%) devorppA
Skin redness 1 (less than 1%) 4 (1%) 1 (less than 1%) 2 (2%) 1 (less than 1%)
Headache 3 (1%) 2 (less than 1%) 0 1 (less than 1%) 1 (less than 1%)
Sore throat 4 (1%) 1 (less than 1%) 1 (less than 1%) 2 (2%) 0
Dizziness 4 (1%) 0 0 0 0
Cold sores around 4 (1%) 0 2 (less than 1%) 1 (less than 1%) 0
the mouth
Rash 3 (1%) 1 (less than 1%) 1 (less than 1%) 1 (less than 1%) 1 (less than 1%)
Infection of breathing 3 (1%) 1 (less than 1%) 2 (less than 1%) 0 0
passages or lungs
Higher level of a liver 2 (less than 1%) 0 3 (1%) 1 (less than 1%) 0
blood test (called
ALT)
High blood pressure 1 (less than 1%) 0 1 (less than 1%) 0 2 (2%)
Vomiting 2 (less than 1%) 1 (less than 1%) 1 (less than 1%) 0 2 (2%)
Ear infection 0 0 0 2 (2%) 0
Lower than normal 0 0 0 0 2 (2%)
number of white
blood cells called
neutrophils
Bladder (or urinary) 0 2 (less than 1%) 0 2 (2%) 0
infection
This section only shows the most frequently reported side effects considered by the
study doctor as related to treatment. No single clinical study can give a complete
picture of the benefits and risks of a medicine. Information about other side effects
may be available at the websites listed at the end of this summary.
8